dr. finn on current and emerging agents in the field of hcc
Published 6 years ago • 51 plays • Length 1:45
Download video MP4
Download video MP3
Similar videos
-
5:14
emerging agents for treatment of hcc
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
2:18
dr. finn on biomarkers of response in hcc
-
2:09
dr. finn on finding a biomarker for patients with hcc
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
4:32
overview and diagnosis of hcc
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
36:10
fulminant hepatic failure current and emerging therapies
-
7:28:41
day-2 | inasl - mid-term single theme meeting on hepatocellular carcinoma (hcc)
-
37:00
surgery for nets – gi, liver, and pancreas
-
1:25
richard finn, md, elaborates on current treatment options & sequencing of tkis in hcc
-
1:57
dr. finn on recent advances in the treatment of liver cancer
-
2:08
dr. finn on studies of pembrolizumab in hepatocellular carcinoma
-
1:00
richard finn, md, considers the effectiveness of sorafenib in newly diagnosed hcc
-
1:34
dr. finn on results of resource study in liver cancer
-
2:03
dr. finn discusses the pooled analysis of reach and reach-2 in hcc
-
5:26
hcc whiteboard #1: the epidemiology of hepatocellular carcinoma and current standard of care
-
2:13
richard s. finn, md, offers opinion on the role of frontline atezolizumab bevacizumab in hcc
-
2:14
dr. finn recaps second-line advancements in hcc
-
55:23
hepatocellular carcinoma: a guide to integrating emerging therapies into current treatment paradigms
-
1:59
richard s. finn, md, offers opinion on the broader role of i-o in the management of hcc
Clip.africa.com - Privacy-policy